Sort   by:  
 Page size 
ProteomicsLC-MS/MS identification of differentially expressed proteins in carboplatin resistant Triple Negative Breast Cancer
Triple negative breast cancer (TNBC) is the subtype of breast cancer most lacking in efficient treatment options. Although many TNBCs show remarkable responses to carboplatin-based chemotherapy, they often develop resistance over time. With increasing use of carboplatin in clinics, there is a pressi...
ORGANISM(S): Homo sapiens (Human) 
2021-07-07 | PXD021726 | Pride
Lc-ms/ms identification of differentially expressed proteins in carboplatin resistant triple negative breast cancer 
Genomicsena-DATASET-VIB-13-03-2012-14:05:46:504-2 - samples
Tumor sample of a serious ovarian carcinoma
EGAD00001000139 | EGA
GenomicsOvarian & matched normal (Genotypes) - samples
Ovarian & matched normal (Genotypes)
EGAD00010000220 | EGA
Genomicsena-DATASET-VIB-13-03-2012-14:07:27:404-3 - samples
Blood sample of serious ovarian carcinoma patient
EGAD00001000140 | EGA
Genomicsena-DATASET-VIB-29-07-2013-12:55:51:690-38 - samples
DNA replication errors occurring in mismatch repair (MMR) deficient cells persist as mismatch mutations and predispose to a range of tumors. Here, we sequenced the first whole-genomes from MMR-deficient endometrial tumors.
EGAD00001000641 | EGA
GenomicsComplete Genomics paired end sequencing; Ovarian cancer
We sequenced the genomes from a monozygotic twin discordant for schizophrenia and a tumor-normal pair of an ovarian cancer patient. Using whole-genome twin data to discriminate between correctly identified single nucleotide variants (SNVs) and errors a strategy for the accurate detection of SNVs was...
EGAS00001000158 | EGA
GenomicsSignatures of mismatch repair deficiency in cancer genomes
DNA replication errors occurring in mismatch repair (MMR) deficient cells persist as mismatch mutations and predispose to a range of tumors. Here, we sequenced the first whole-genomes from MMR-deficient tumors and observed that mutation rates were drastically increased relative to MMR-proficient end...
EGAS00001000182 | EGA
GenomicsDAC EGAS00000000094
Data Access Committee EGAC00001000041
EGAC00001000041 | EGA
Sort   by:  
 Page size